GPR158 and neurodegenerative disease: Although the precise biological mechanisms underlying the OCN/GPR158 signaling pathway remain incompletely understood, its association with neurodegenerative diseases (NDs), including Alzheimer’s disease (AD) and Parkinson’s disease (PD), is becoming increasingly evident.